Institutions Holding Call Options on Neurocrine Biosciences Inc (NBIX)
This table provides information about the call option holders of Neurocrine Biosciences Inc (NBIX). We have compiled data on the institutions that hold call options on the stock, with a total of 799,600 call options outstanding, which have been reported (via 13F filing form) to have a value of $103 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|
Jane Street Group, LLC
New York, NY |
May 19, 2025 Q1 2025 |
446,800
calls
|
$57.2 Million
0.01% of portfolio
|
N/A
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
104,500
calls
|
$13.4 Million
0.0% of portfolio
|
N/A
|
|
|
Twin Tree Management, LP
Dallas, TX |
Jul 28, 2025 Q2 2025 |
71,300
calls
|
$9.13 Million
0.02% of portfolio
|
N/A
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
57,000
calls
|
$7.3 Million
0.0% of portfolio
|
N/A
|
|
|
J. Goldman & CO LP
New York, NY |
May 15, 2025 Q1 2025 |
53,000
calls
|
$6.79 Million
0.15% of portfolio
|
N/A
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
46,600
calls
|
$5.97 Million
0.0% of portfolio
|
Q1 2025
Added 556.34%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
19,500
calls
|
$2.5 Million
0.0% of portfolio
|
N/A
|
|
|
Peak6 Investments LLC
Chicago, IL |
Nov 13, 2024 Q3 2024 |
900
calls
|
$115,236
0.0% of portfolio
|
N/A
|